Latest filing published 27 Feb 2024 for Supernus Pharmaceuticals, INC..
Insider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +59.7%Entry US$5.14 · Close at T+365 US$8.21
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
John M. Siebert: trading record in brief
John M. Siebert (board member) discloses dealings in 2 companies, chiefly Supernus Pharmaceuticals, Inc. and Aradigm Corp. Between 15 May 2009 and 23 February 2024, the trades on record add up to 21 filings.
Every open-market trade on record is a purchase: 3 purchases worth €68k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 10 share grants and 8 option exercises.
In size, the median ticket on the buying side is €13k.
The newest entry dates from 27 February 2024: a share grant, in Supernus Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 4,976 days ago, on 25 March 2013. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John M. Siebert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,886 shares0Common StockSEC:0001104659-24-028277:0
- 3,882 shares0Common StockSEC:0001104659-23-025383:0
- 4,222 shares0Common StockSEC:0001104659-22-026096:0
- 15,000 shares@ US$12.98100.0% of flowCommon StockSEC:0001104659-21-104206:0
- 5,211 shares@ US$23.9941.1% of flowCommon StockSEC:0001104659-20-024846:0
- 10,000 shares@ US$9.1314.3% of flowCommon StockSEC:0001104659-19-037264:0
- 10,000 shares@ US$9.1314.5% of flowCommon StockSEC:0001104659-19-024504:0
- 8,722 shares@ US$7.9010.6% of flowCommon StockSEC:0001104659-19-012547:0
- 7,457 shares@ US$9.2410.6% of flowCommon StockSEC:0001104659-19-012547:1
- 2,188 shares@ US$4.24Common StockSEC:0001104659-15-002178:0
- 2,187 shares@ US$4.24Common StockSEC:0001104659-14-003892:0
- 100,000 shares@ US$0.15Common StockSEC:0001209191-13-033343:0
- 3,000 shares@ US$5.50Common StockSEC:0001181431-13-018549:0Canonical exit: 19 Jun 2013 (T+90)
- 2,188 shares@ US$4.24Common StockSEC:0001181431-12-065176:0
- 7,000 shares@ US$8.14Common StockSEC:0001181431-12-062652:0Canonical exit: 4 Mar 2013 (T+90)
- 100,000 shares0Common StockSEC:0001209191-12-031542:0
- 3,000 shares@ US$5.00Common StockSEC:0001179110-12-007837:0Canonical exit: 2 Aug 2012 (T+90)
- 78,947 shares0Common StockSEC:0001209191-11-031994:0
- 125,000 shares0Common StockSEC:0001209191-10-028539:0
- 93,750 shares0Common StockSEC:0001209191-09-030894:0
- 93,750 shares0Common StockSEC:0001209191-09-027701:0
21 of 21 declarations
